Global Blood Therapeutics (GBT) Stock: Why It Surged Over 35% Today

By Amit Chowdhry ● Aug 4, 2022
  • The stock price of Global Blood Therapeutics (GBT) surged by over 35% during intraday trading today. This is why.

The stock price of Global Blood Therapeutics (GBT) surged by over 35% during intraday trading today. Investors are responding positively to a report from Bloomberg that the company is attracting takeover interest.

There are several large pharma companies that are considering a potential deal, but they were not identified due to confidentiality. Global Blood Therapeutics is also reportedly working with advisers for evaluating the interest. But there is no guarantee that a deal will go through.